<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <italic class="italic">Zinc</italic> is active against some antibiotic-resistant microorganisms owing to its intricate antibacterial mechanism [
 <xref rid="B168-molecules-23-02392" ref-type="bibr" class="xref">168</xref>,
 <xref rid="B169-molecules-23-02392" ref-type="bibr" class="xref">169</xref>]. 
 <italic class="italic">Zinc oxide (ZnO)</italic> represents the core form studied for its antibacterial effect. ZnO NPs are capable of yielding ROS that impede 
 <italic class="italic">E. coli</italic> and 
 <italic class="italic">S. aureus</italic> biofilm development [
 <xref rid="B170-molecules-23-02392" ref-type="bibr" class="xref">170</xref>,
 <xref rid="B171-molecules-23-02392" ref-type="bibr" class="xref">171</xref>,
 <xref rid="B172-molecules-23-02392" ref-type="bibr" class="xref">172</xref>]. Moreover, it was reported that ZnO NPs, at proper concentrations, have antibacterial activity without affecting normal cells [
 <xref rid="B26-molecules-23-02392" ref-type="bibr" class="xref">26</xref>,
 <xref rid="B173-molecules-23-02392" ref-type="bibr" class="xref">173</xref>]. When ZnO was embedded into a chitosan-dextran hydrogel, it proved to have proper antimicrobial properties and be an appropriate component in wound dressings [
 <xref rid="B174-molecules-23-02392" ref-type="bibr" class="xref">174</xref>]. Knorasani et al. produced nanocomposite dressings by incorporating ZnO NPs into heparinized PVA/chitosan/hydrogels. The results showed this composite dressingsâ€™ aantibacterial effect against 
 <italic class="italic">E. coli</italic> and 
 <italic class="italic">S. aureus</italic> was enhanced with more than 70% by adding ZnO NPs into the hydrogels, as compared to the sample without ZnO NPs. Furthermore, in vitro tests performed on mouse fibroblast cells revealed that the nanocomposites are fully biocompatible [
 <xref rid="B175-molecules-23-02392" ref-type="bibr" class="xref">175</xref>].
</p>
